PYC Therapeutics Limited (ASX:PYC)

PYC Therapeutics Revenue

In the fiscal year ending June 30, 2025, PYC Therapeutics had annual revenue of 23.49 million AUD with 6.51% growth. PYC Therapeutics had revenue of 11.66 million in the half year ending June 30, 2025, a decrease of -5.49%.

• Revenue: 23.49M
• Revenue Growth: +6.51%
• P/S Ratio: 29.79
• Revenue / Employee: 4.70M
• Employees: 5
• Market Cap: 699.91M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	23.49M	1.44M	6.51%
Jun 30, 2024	22.06M	6.25M	39.56%
Jun 30, 2023	15.81M	-236.57K	-1.47%
Jun 30, 2022	16.04M	12.97M	421.83%
Jun 30, 2021	3.07M	678.66K	28.33%